Accelerate with Confidence: Research-Based Insights to guide CDMO-CRO Partnership Decisions

In drug development, every delay has a price—lost time, lost opportunity, and lost market share. Escalating costs, complex modalities, strict regulations, and supply chain challenges are making speed and precision more critical than ever. Yet many programs remain slowed by fragmented outsourcing models that create inefficiencies, communication gaps, and costly handoffs.

Important new research from the Tufts Center for the Study of Drug Development points to a more effective path. Using a modeling approach that quantifies both the financial returns and risk-adjusted value of development decisions, the researchers found that integrating CDMO, CRO, and clinical supply capabilities with one a single partner can shorten timelines, reduce costs, and strengthen control.

This webinar will cover key findings from the study along with case-driven examples of how biotech and biopharma companies are applying these strategies to reach milestones faster and with greater strategic control.

What You’ll Learn in This Webinar :

• The research methods and modeling techniques behind the Tufts study
• How Thermo Fisher Scientific’s Accelerator™ Drug Development framework delivers on the promise of the single-vendor model
• Real-world case studies illustrating the value of this approach

Who Should Attend :

• Biotech & Pharma Professionals – From established, new, and emerging organizations
• C-Suite Executives – CEOs, CFOs, Directors, and Senior Managers
• CMC Professionals – Chemistry, Manufacturing & Controls Directors and Managers